期刊文献+
共找到23篇文章
< 1 2 >
每页显示 20 50 100
粪便免疫化学检测结果与体重、血脂等的相关性分析 被引量:3
1
作者 郭颖 裴冬梅 张耐思 《现代肿瘤医学》 CAS 北大核心 2021年第6期1017-1020,共4页
目的:探讨粪便免疫化学检测结果特点及与体重、血脂等的相关性。方法:选取2019年1月至12月于中国医科大学附属盛京医院体检中心完善粪便免疫化学检测的人群1249例为研究对象,采用乳胶凝集免疫比浊法对其进行粪便潜血检测,并记录其年龄... 目的:探讨粪便免疫化学检测结果特点及与体重、血脂等的相关性。方法:选取2019年1月至12月于中国医科大学附属盛京医院体检中心完善粪便免疫化学检测的人群1249例为研究对象,采用乳胶凝集免疫比浊法对其进行粪便潜血检测,并记录其年龄、病史、血压、血脂、血糖、血尿酸等一般资料。结果:粪便免疫化学检测阳性者212例,阳性率为16.97%,男性阳性率高于女性(P<0.05)。青年组和老年组粪便免疫化学检测阳性率与中年组比较,差异具有统计学意义(P<0.05),而青年组和老年组之间差异没有统计学意义(P>0.05)。粪便免疫化学检测阳性的单因素分析发现,收缩压、舒张压、体质量指数、血糖空腹、甘油三酯、高密度胆固醇、低密度胆固醇、载脂蛋白B、血尿酸差异有统计学意义(P<0.05)。Logistic回归分析结果显示,体质量指数、甘油三酯、高密度胆固醇、低密度胆固醇为粪便免疫化学检测阳性的危险因素(P<0.05)。结论:人群中超重或肥胖、血脂异常是粪便免疫化学检测阳性的重要风险因素。 展开更多
关键词 粪便免疫化学检测 体重 血脂
下载PDF
对结肠癌高危患者进行粪便免疫化学检测的态度:英国全科医生的网上调查
2
作者 VON WAGNER C STOFFEL S FREEMAN M 《中国全科医学》 CAS 北大核心 2018年第36期4510-4510,共1页
背景在初级保健中,越来越多采用定量粪便免疫化学试验(FIT)排除高危症状患者结直肠癌(CRC).目的本研究旨在探讨全科医生对紧急2周等待(2WW)转诊和采用FIT的态度和意愿.设计与场所涉及英国1024位全科医生的一项在线横断面调查.方... 背景在初级保健中,越来越多采用定量粪便免疫化学试验(FIT)排除高危症状患者结直肠癌(CRC).目的本研究旨在探讨全科医生对紧急2周等待(2WW)转诊和采用FIT的态度和意愿.设计与场所涉及英国1024位全科医生的一项在线横断面调查.方法采用Logistic回归模型探讨全科医生采用FIT而非2WW转诊的可能性,并使用优势比(OR)和95%可信区间(95%CI).结果略超过1/3的全科医生(n=365)倾向于采用FIT来排除2WW转诊的需要.以下全科医生更愿意采用FIT:年龄在36-45岁〔OR=1.59,95%CI(1.04,2.44)〕;年龄在46-55岁〔OR=1.99,95%CI(1.14,3.47)〕;认为FIT高度准确〔OR=1.63,95%CI(1.16,2.29)〕;认为与结肠镜检查相比,FIT对患者更有好处〔OR=2.02,95%CI(1.46,2.79)〕;对FIT的好处非常自信〔OR=2.14,95%CI(1.46,3.16)〕.如果全科医生在过去1年中有超过10次紧急2WW转诊〔OR=0.62,95%CI(0.40,0.94)〕,那么其更不愿意采用FIT,并认为需要更长时间的会诊〔OR=0.61,95%CI(0.44,0.83)〕.结论目前在初级保健中将FIT作为排除CRC的接受度较低,不到一半的全科医生认为其比结肠镜检查准确.未来任何建议在高危症状患者中采用FIT而非紧急2WW转诊排除CRC的指导方针均需要强化支持教育延伸,以提高全科医生对FIT准确性及其应用的信心. 展开更多
关键词 免疫化学检测 全科医生 横断面调查 高危患者 LOGISTIC回归模型 英国 粪便 结肠癌
下载PDF
口服抗凝血药或非甾体抗炎药不会影响结肠癌粪便免疫化学检测的准确性
3
《实用肿瘤学杂志》 CAS 2018年第3期233-233,共1页
目前,大多数结直肠癌筛查人群优先选择粪便免疫化学检测(FIT),而老年人群中接受口服抗凝血药(OACS)或非甾体抗炎药(NSAID)进行心血管事件预防的比例较高,可能会刺激结肠良性和癌前病变出血,导致FIT结果假阳性。近日研究人员就OACs... 目前,大多数结直肠癌筛查人群优先选择粪便免疫化学检测(FIT),而老年人群中接受口服抗凝血药(OACS)或非甾体抗炎药(NSAID)进行心血管事件预防的比例较高,可能会刺激结肠良性和癌前病变出血,导致FIT结果假阳性。近日研究人员就OACs和NSAIDs治疗对FIT检测的影响进行了研究。本次研究为系统综述和荟萃分析研究,收集截止2017年6月的相关研究资料. 展开更多
关键词 免疫化学检测 非甾体抗炎药 口服抗凝血药 结肠癌 粪便 NSAIDS 老年人群 心血管事件
下载PDF
比较结肠镜与粪便免疫化学检测在结直肠癌筛查中的作用
4
《癌症进展》 2012年第3期201-201,共1页
背景结肠镜检查和粪便免疫化学检测(FIT)是目前筛查结直肠癌公认的策略。方法研究者选取了50~69岁的无症状成人进行随机、对照试验,比较1次结肠镜检查(即结肠镜组,共26703名受试者)和每2年1次的FIT(即FIT组,共26599名受试者)... 背景结肠镜检查和粪便免疫化学检测(FIT)是目前筛查结直肠癌公认的策略。方法研究者选取了50~69岁的无症状成人进行随机、对照试验,比较1次结肠镜检查(即结肠镜组,共26703名受试者)和每2年1次的FIT(即FIT组,共26599名受试者)检查对于结直肠癌的筛查效果。研究目标是结直肠癌10年死亡率。结果FIT组的参加率高于结肠镜组(34.2%vs24.6%,P〈0.001)。 展开更多
关键词 结肠镜检查 免疫化学检测 结直肠癌 癌筛查 粪便 FIT 对照试验 年死亡率
下载PDF
粪便免疫化学检测在结直肠癌筛查中的价值
5
作者 周月阳 李娜 +7 位作者 陆斌 骆晨雨 张愉涵 骆家辉 卢明 蔡洁 代敏 陈宏达 《中华肿瘤杂志》 CAS CSCD 北大核心 2023年第11期911-918,共8页
筛查与早诊早治已被证实是降低结直肠癌发病率和死亡率的有效手段。结肠镜结合病理检查是结直肠癌筛查的金标准,但因结肠镜检查具有侵入性、费用高且需要专业内镜医师操作等因素,不适合直接用于大规模人群筛查。粪便免疫化学检测(FIT)... 筛查与早诊早治已被证实是降低结直肠癌发病率和死亡率的有效手段。结肠镜结合病理检查是结直肠癌筛查的金标准,但因结肠镜检查具有侵入性、费用高且需要专业内镜医师操作等因素,不适合直接用于大规模人群筛查。粪便免疫化学检测(FIT)是国际权威结直肠癌筛查指南推荐的筛查技术之一,已在世界各国人群结直肠癌筛查项目中广泛应用。文章从技术原理、筛查效能、筛查策略、人群效果和效益等不同方面阐述了FIT在结直肠癌筛查中的价值,介绍了目前在中国人群中采用FIT进行结直肠癌筛查的现状,指出了FIT筛查所面临的挑战,以期优化基于FIT的人群结直肠癌筛查策略,为开展高效的结直肠癌筛查提供理论参考。 展开更多
关键词 结直肠肿瘤 筛查 粪便免疫化学检测
原文传递
高危因素量化问卷与亚太结直肠癌筛查评分及分别联合粪便免疫化学检测在进展期结直肠肿瘤筛查中效果的比较 被引量:5
6
作者 朱柠 黄彦钦 +3 位作者 宋永茂 张苏展 郑树 袁瑛 《中华胃肠外科杂志》 CSCD 北大核心 2022年第7期612-620,共9页
目的评价高危因素量化问卷(HRFQ)与亚太结直肠癌筛查评分(APCS)及分别联合粪便免疫化学检测(FIT)在进展期结直肠肿瘤筛查中的效果,为结直肠肿瘤早筛方法的优化提供依据。方法采用回顾性队列研究的方法,总结分析2017年3月至2018年7月间... 目的评价高危因素量化问卷(HRFQ)与亚太结直肠癌筛查评分(APCS)及分别联合粪便免疫化学检测(FIT)在进展期结直肠肿瘤筛查中的效果,为结直肠肿瘤早筛方法的优化提供依据。方法采用回顾性队列研究的方法,总结分析2017年3月至2018年7月间在浙江嘉善县对40~74岁户籍人口进行结直肠肿瘤筛查的结果。排除合并严重疾患以致不适合行结肠镜检查者以及精神、行为异常不能配合筛查者。符合HRFQ问卷以下任何一项或以上者,列为HRFQ高危人群:(1)一级亲属有结直肠癌史;(2)本人有癌症史(任何恶性肿瘤病史);(3)本人有肠道息肉史;(4)同时具有以下两项及两项以上者:慢性便秘(近两年来便秘每年在2个月以上);慢性腹泻(近两年来腹泻累计持续超过3个月,每次发作持续时间在1周以上);黏液血便;不良生活事件史(发生在近20年内,并在事件发生后对调查对象造成较大精神创伤或痛苦);慢性阑尾炎或阑尾切除史;慢性胆道疾病史或胆囊切除史。本研究中,将HRFQ评估为高危者记为“HRFQ(+)”,非高危者记为“HRFQ(-)”。APCS问卷根据年龄、性别、家族史和吸烟4项危险因素进行风险评分:(1)年龄:50~69岁为2分,70岁及以上为3分;(2)性别:男性为1分,女性为0分;(3)家族史:一级亲属患结直肠癌2分;(4)吸烟:当前或过去吸烟1分,不吸烟0分。将人群分为低危(0~1分)、中危(2~3分)、高危(4~7分)。将APCS评估为高危者记为“APCS(+)”,中、低危者记为“APCS(-)”。粪便免疫化学检测(FIT)阳性的血红蛋白阈值设定为100μg/L。将APCS评估为高危者且FIT阳性记为“APCS+FIT(+)”,将APCS评估为高危者且FIT阴性、APCS评估为中低危者且FIT为阳性和APCS评估为中低位者且FIT为阴性记为“APCS+FIT(-)”。观察指标包括:(1)队列人群筛查顺应率及进展期结直肠肿瘤检出情况;(2)HRFQ与APCS及其联合FIT筛检进展期结直肠肿瘤的阳性预测值、阴性预测值、灵敏度和特异度;(3)比较HRFQ与APCS问卷对不同结直肠病变检出率。采用SPSS 21.0软件,绘制受试者工作特征曲线(ROC),评价HRFQ与APCS及分别联合FIT筛查进展期结直肠肿瘤的临床价值。结果浙江嘉善2017—2018年共筛查队列目标人群53268人,实际完成问卷调查42093人,顺应率为79.02%。接受肠镜检查者8145人,HRFQ阳性人群(5320例)中共3607例接受了结肠镜检查,肠镜顺应率为67.80%;确诊结直肠癌8例,进展期结直肠腺瘤88例。APCS阳性人群(11942例)中共2977例接受了结肠镜检查,肠镜顺应率为24.93%;确诊结直肠癌17例、进展期结直肠腺瘤148例。HRFQ筛查的阳性率低于APCS[12.6%(5320/42093)比28.4%(11942/42093),χ^(2)=3195.547,P<0.001]。FIT阳性人群(6223例)中共4894例接受了结肠镜检查,肠镜顺应率为78.64%;确诊结直肠癌34例、进展期腺瘤224例。HRFQ与APCS及其联合FIT筛检进展期结直肠肿瘤的阳性预测值分别为2.67%、5.54%、5.44%、8.56%;阴性预测值分别为94.89%、96.85%、96.11%和96.99%;灵敏度分别为29.27%、50.30%、12.20%和39.02%;特异度分别为55.09%、64.03%、91.11%和82.51%。将HRFQ、APCS、FIT、HRFQ+FIT及APCS+FIT构建ROC曲线,提示APCS+FIT筛检进展期结直肠肿瘤的效能最高(曲线下面积:0.608,95%CI:0.574~0.642)。HRFQ与APCS问卷对不同结直肠病变的检出率比较结果显示,两种问卷对炎性息肉和增生性息肉的检出率差异没有统计学意义(均P>0.05),但APCS问卷与HRFQ问卷比较,在非进展期腺瘤[26.10%(777/2977)比19.43%(701/3607),χ^(2)=51.228,P<0.001]、进展期腺瘤[4.97%(148/2977)比2.44%(88/3607),χ^(2)=30.249,P<0.001]及结直肠癌[0.57%(17/2977)比0.22%(8/3607),χ^(2)=5.259,P=0.022]方面其检出率要高于HRFQ(均P<0.05)。结论APCS比HRFQ有更高的进展期结直肠肿瘤检出率,APCS联合FIT可以进一步提高进展期结直肠肿瘤筛查的有效性。 展开更多
关键词 结直肠癌 进展期 结直肠腺瘤 进展期 筛查 高危因素量化问卷 亚太结直肠癌筛查评分 粪便免疫化学检测 检出率
原文传递
粪便免疫化学试验筛查大肠癌的研究进展
7
作者 曾凡 陈晨 +2 位作者 黄士美 张大涯 白飞虎 《海南医学院学报》 2023年第22期1748-1754,共7页
大肠癌已经成为全世界第三大常见癌症,癌症相关的第二大死因。早期筛查可降低CRC的发生率和死亡率。随着粪便免疫化学试验的发展,FIT已经成为全世界大肠癌高危人群筛查大肠癌的重要手段。本文就FIT筛查CRC的研究进展进行阐述。
关键词 大肠癌 粪便免疫化学检测 筛查
下载PDF
粪便miRNA675-5p联合qFIT检测对结直肠癌筛查的诊断价值
8
作者 陈洁 王阳 +3 位作者 金曙 李欢 龙辉 吴清明 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2023年第4期540-544,共5页
目的探讨粪便miRNA675-5p联合qFIT在结直肠癌筛查中的诊断价值。方法纳入2016年1月至2021年12月于武汉科技大学附属天佑医院和十堰市太和医院就诊的173例患者,收集其临床资料及粪便标本,包括48例结直肠癌组、46例腺瘤组、42例息肉组、3... 目的探讨粪便miRNA675-5p联合qFIT在结直肠癌筛查中的诊断价值。方法纳入2016年1月至2021年12月于武汉科技大学附属天佑医院和十堰市太和医院就诊的173例患者,收集其临床资料及粪便标本,包括48例结直肠癌组、46例腺瘤组、42例息肉组、37例正常对照组。采用qRT-PCR法检测粪便miRNA675-5p,定量粪便免疫化学检测(qFIT)检测粪便潜血。采用ROC曲线评估qFIT及miRNA675-5p联合qFIT检测对结直肠癌及腺瘤的诊断价值。结果结直肠癌组的qFIT值[259.94(36.25,758.55)]明显高于腺瘤组[0(0,13.42)]、息肉组[0(0,0)]、正常对照组[0(0,0)],差异有统计学意义(均P<0.01);腺瘤组高于息肉组和正常对照组,差异有统计学意义(P<0.05,P<0.01)。结直肠癌组qFIT敏感度为85.4%,特异度为100%;腺瘤组qFIT敏感度为28.3%,特异度为97.3%。联合检测(miRNA675-5p联合qFIT)结直肠癌组敏感度100%,特异度89.2%;腺瘤组敏感度71.7%,特异度86.5%。结直肠癌组、腺瘤组联合检测优于qFIT单独检测,差异有统计学意义(均P<0.01)。结论miRNA675-5p联合qFIT检测能够提高早期结直肠癌筛查诊断效能。 展开更多
关键词 结直肠癌 miRNA675-5p 定量粪便免疫化学检测
下载PDF
高危型HPV分型联合P16/Ki-67免疫化学双染检测应用于宫颈癌筛查的价值 被引量:1
9
作者 郭玲 张静 +1 位作者 王兵 冯元元 《临床医学》 CAS 2023年第6期73-75,共3页
目的 分析高危型人乳头瘤病毒(HPV)分型联合P16/Ki-67免疫化学双染检测应用于宫颈癌筛查的效果。方法 选取2021年8月至2022年8月于信阳市中心医院行宫颈癌筛查的169例女性为研究对象,均行高危型HPV分型、P16/Ki-67免疫化学双染检测,以... 目的 分析高危型人乳头瘤病毒(HPV)分型联合P16/Ki-67免疫化学双染检测应用于宫颈癌筛查的效果。方法 选取2021年8月至2022年8月于信阳市中心医院行宫颈癌筛查的169例女性为研究对象,均行高危型HPV分型、P16/Ki-67免疫化学双染检测,以病理检查为“金标准”,统计分析不同检测方法在宫颈癌筛查中的效果。结果 病理检查共检出84例阳性。高危型HPV分型联合P16/Ki-67免疫化学双染检测的灵敏度为96.43%(81/84)、准确度为97.63%(165/169)、阴性预测值为96.55%(84/87),高于高危型HPV分型检查[83.33%(70/84)、89.35%(151/169)、85.26%(81/95)]以及P16/Ki-67免疫化学双染检测[85.71%(72/84)、91.12%(154/169)、87.23%(82/94)],差异有统计学意义(P<0.05)。kappa检验显示:高危型HPV分型联合P16/Ki-67免疫化学双染检测与病理检查结果的一致性极好(kappa值=0.953,P=0.000)。结论 高危型HPV分型联合P16/Ki-67免疫化学双染检测可有效筛查出宫颈癌,减少误诊、漏诊率,为临床诊疗提供可靠的依据。 展开更多
关键词 宫颈癌 高危型人乳头瘤病毒分型 免疫化学双染检测 诊断效能
原文传递
饲料中霉菌毒素的毒害机理、检测方法和控制措施 被引量:7
10
作者 张治成 《现代畜牧科技》 2019年第6期58-59,共2页
霉菌毒素是真菌代谢生成的次级代谢物,主要在丝状真菌的孢子和菌丝体内存在,可导致多种物质如饲料、食品、粮食等发生污染。饲料在加工或者贮存的过程中稍不注意就会污染霉菌,从而使其含有大量的霉菌毒素,导致饲料营养价值降低,动物长... 霉菌毒素是真菌代谢生成的次级代谢物,主要在丝状真菌的孢子和菌丝体内存在,可导致多种物质如饲料、食品、粮食等发生污染。饲料在加工或者贮存的过程中稍不注意就会污染霉菌,从而使其含有大量的霉菌毒素,导致饲料营养价值降低,动物长时间饲喂或者大量采食这种饲料就会发生急性或者慢性中毒,同时动物产品中残留的霉菌毒素还会危害人类的健康。现概述饲料中霉菌毒素的毒害机理、常用检测方法以及控制措施。 展开更多
关键词 饲料 霉菌毒素 毒害机理 检测方法 薄层层析法 质谱法 免疫化学检测 控制措施
下载PDF
多靶点粪便FIT-DNA检测对中国人群结直肠癌筛查价值的meta分析 被引量:1
11
作者 申艺 向德兵 孙贵银 《重庆医学》 CAS 2023年第11期1711-1715,1721,共6页
目的探讨粪便多靶点免疫化学粪便实验(FIT)-DNA联合检测对中国人群结直肠癌(CRC)筛查的临床价值。方法通过计算机检索中国知网、万方数据知识服务平台、维普中文期刊服务平台、PubMed、EMBase数据库,应用EndNote X9管理文献,根据纳入和... 目的探讨粪便多靶点免疫化学粪便实验(FIT)-DNA联合检测对中国人群结直肠癌(CRC)筛查的临床价值。方法通过计算机检索中国知网、万方数据知识服务平台、维普中文期刊服务平台、PubMed、EMBase数据库,应用EndNote X9管理文献,根据纳入和排除标准,应用QUADAS-2表进行文献质量评价,提取数据应用Stata MP 17.0进行系统评价。结果最终纳入9篇文献,17项研究,8487个筛查对象。其结果显示FIT-DNA筛查CRC和进展期腺瘤(AA)的合并灵敏度分别为94%和50%,合并特异度分别为91%和90%。结论FIT-DNA是一个极有潜力的新型CRC筛查方法。 展开更多
关键词 多靶点 粪便免疫化学检测-DNA检测 结直肠癌 进展期腺瘤 筛查 META分析
下载PDF
Genetic Correction and Hepatic Differentiation of Hemophilia B-specific Human Induced Pluripotent Stem Cells 被引量:2
12
作者 何琼 王惠荟 +4 位作者 程涛 袁卫平 马钰波 蒋永平 任志华 《Chinese Medical Sciences Journal》 CAS CSCD 2017年第3期135-144,共10页
Objective To genetically correct a disease-causing point mutation in human induced pluripotent stem cells (iPSCs) derived from a hemophilia B patient. Methods First, the disease-causing mutation was detected by ... Objective To genetically correct a disease-causing point mutation in human induced pluripotent stem cells (iPSCs) derived from a hemophilia B patient. Methods First, the disease-causing mutation was detected by sequencing the encoding area of human coagulation factor IX (F IX) gene. Genomic DNA was extracted from the iPSCs, and the primers were designed to amplify the eight exons of F IX. Next, the point mutation in those iPSCs was genetically corrected using CRISPR/Cas9 technology in the presence of a 129-nucleotide homologous repair template that contained two synonymous mutations. Then, top 8 potential off-target sites were subsequently analyzed using Sanger sequencing. Finally, the corrected clones were differentiated into hepatocyte-like cells, and the secretion of F IX was validated by immunocytochemistry and ELISA assay.Results The cell line bore a missense mutation in the 6th coding exon (c.676 C〉T) of F IX gene. Correction of the point mutation was achieved via CRISPR/Cas9 technology in situ with a high efficacy at about 22% (10/45) and no off-target effects detected in the corrected iPSC clones. F IX secretion, which was further visualized by immunocytochemistry and quantified by ELISA in vitro, reached about 6 ng/ml on day 21 of differentiation procedure. Conclusions Mutations in human disease-specific iPSCs could be precisely corrected by CRISPR/Cas9 technology, and corrected cells still maintained hepatic differentiation capability. Our findings might throw a light on iPSC-based personalized therapies in the clinical application, especially for hemophilia B. 展开更多
关键词 hemophilia B human induced pluripotent stem cells CRISPR/Cas9 genetic correction hepatic differentiation
下载PDF
Chronic intestinal pseudo-obstruction 被引量:12
13
作者 Alexandra Antonucci Lucia Fronzoni +7 位作者 Laura Cogliandro Rosanna F Cogliandro Carla Caputo Roberto De Giorgio Francesca Pallotti Giovanni Barbara Roberto Corinaldesi Vincenzo Stanghellini 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第19期2953-2961,共9页
Chronic intestinal pseudo-obstruction (CIPO) is a se- vere digestive syndrome characterized by derangement of gut propulsive motility which resembles mechanical obstruction, in the absence of any obstructive process. ... Chronic intestinal pseudo-obstruction (CIPO) is a se- vere digestive syndrome characterized by derangement of gut propulsive motility which resembles mechanical obstruction, in the absence of any obstructive process. Although uncommon in clinical practice, this syndrome represents one of the main causes of intestinal failure and is characterized by high morbidity and mortality. It may be idiopathic or secondary to a variety of diseases. Most cases are sporadic, even though familial forms with either dominant or recessive autosomal inheritance have been described. Based on histological features in- testinal pseudo-obstruction can be classified into three main categories:neuropathies, mesenchymopathies, and myopathies, according on the predominant involvement of enteric neurones, interstitial cells of Cajal or smooth muscle cells, respectively. Treatment of intestinal pseu- do-obstruction involves nutritional, pharmacological and surgical therapies, but it is often unsatisfactory and the long-term outcome is generally poor in the majority of cases. 展开更多
关键词 Chronic intestinal pseudo-obstruction Smallbowel manometry IMMUNOHISTOCHEMISTRY PROKINETICS Intestinal transplantation
下载PDF
Reliability of a Tissue Microarray in Detecting Thyroid Transcription Factor-1 Protein in Lung Carcinomas 被引量:1
14
作者 Xiaoyan Bai Hong Shen 《Chinese Journal of Clinical Oncology》 CSCD 2007年第1期9-15,共7页
OBJECTIVE To compare the expression of the thyroid transcription factor-1 (TTF-1) in human normal adult type Ⅱ alveolar epithelial cells, embryonic pneumocytes and cancer cells of lung carcinoma and metastatic lymp... OBJECTIVE To compare the expression of the thyroid transcription factor-1 (TTF-1) in human normal adult type Ⅱ alveolar epithelial cells, embryonic pneumocytes and cancer cells of lung carcinoma and metastatic lymph nodes using a tissue microarray (TMA) along with paired conventional full sections, and to investigate the reliability of tissue microarrays in detecting protein expression in lung carcinoma. METHODS A lung carcinoma TMA including 765 cores was constructed. TTF-1 protein expression in both TMA and paired conventional full sections were detected by the immunohistochemical SP method using a monoclonal antibody to TTF-1. A PU (Positive Unit) of TTF-1 protein was assessed quantitatively by the Leica Q500MC image analysis system with results from the paired conventional full sections as controls. RESULTS There was no significance between TMA and paired conventional full sections in TTF-1 expression in different nuclei of the lung tissue. CONCLUSION TTF-1 protein expression in lung carcinoma detected by TMA was highly concordant with that of paired full sections. TMA is a reliable method in detecting protein expression. 展开更多
关键词 lung carcinoma transcription factor-1(TTF-1) liability. tissue microarray thyroid immunohistochemistry reliability.
下载PDF
Reduced Popdc3 expression correlates with high risk and poor survival in patients with gastric cancer 被引量:4
15
作者 Deng Luo Ming-Liang Lu +5 位作者 Gong-Fang Zhao Hua Huang Meng-Yao Zheng Jiang Chang Lin Lv Jin-Bo Luo 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第19期2423-2429,共7页
AIM: To investigate the expression of Popeye domain containing 3 (Popdc3) and its correlation with clinicopathological features and prognosis of gastric cancer.METHODS: The method of immunohistochemistry was used ... AIM: To investigate the expression of Popeye domain containing 3 (Popdc3) and its correlation with clinicopathological features and prognosis of gastric cancer.METHODS: The method of immunohistochemistry was used to investigate the expression of Popdc3 in 306 cases of human gastric cancer and 84 noncancerous gastric tissues. Simultaneously, the relationship between Popdc3 expression and the survival of the patients was retrospectively analyzed.RESULTS: Popdc3 was detected in 72 (85.71%) of 84 human nontumor mucosa. High expression of Popdc3protein was detected in 78 (25.49%) of 306 human gastric cancer cases, and low expression was detected in 228 (74.51%). Low expression of Popdc3 correlated with depth of invasion (P 〈 0.0001), regional lymph nodes (P 〈 0.0001) and distant metastasis (P =0.02), and tumor, nodes, metastasis (TNM) stages (P 〈 0.0001). On multivariate analysis, only the patient's gender, regional lymph node metastasis, distant metastasis, TNM stages, and the expression of Popdc3 were independent prognostic factors in patients with gastric cancer. The Kaplan-Meier plot showed that low Popdc3 expression had a much more significant effect on the survival of those patients with early-stage tumors X^2 = 104.741, P 〈 0.0001), with a 〉 51.9% reduction in the three-year survival compared with high Popdc3 expression. In late stages, the difference was also significant X^2 = 5.930, P = 0.015), with a 32.6% reduction in the three-year survival.CONCLUSION: Reduced expression of Popdc3 may play a significant role in the carcinogenesis and progression of gastric cancer. Popdc3 may be an independent prognostic factor. 展开更多
关键词 Popeye domain containing 3 Gastric can-cer Cell adhesion molecules METASTASIS Prognosis
下载PDF
Influence of paeonol on expression of COX-2 and p27 in HT-29 cells 被引量:19
16
作者 Jun-Mei Ye Tao Deng Jian-Bao Zhang 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第35期4410-4414,共5页
AIM: To investigate the effect of paeonol on controlling the proliferation of colorectal cancer cell line HT-29 and to discuss its possible mechanism. METHODS: The inhibitory effect of paeonol on proliferation of HT... AIM: To investigate the effect of paeonol on controlling the proliferation of colorectal cancer cell line HT-29 and to discuss its possible mechanism. METHODS: The inhibitory effect of paeonol on proliferation of HT-29 cells was detected by M-I-I- assay. The results of apoptosis were measured by flow cytometry. Immunocytochemical staining was performed to detect the expression of cyclooxygenase-2 (COX-2) and protein p27 in HT-29 cells treated with paeonol at different concentrations. Reverse transcription-polymerase chain reaction (RT- PCR) was used for mRNA analysis. RESULTS: From the data of both MTT and flow cytometry, we observed that cell proliferation was inhibited by different concentrations of paeonol. By immunocytochemical staining, we found that HT-29 cells treated with paeonol (0.024-1.504 mmol/L) reflected reduced expression of COX-2 and increased expression of p27 in a dose-dependent manner. RT-PCR showed that paeonol down-regulated COX-2 and up-regulated p27 in a dose- and time-dependent manner in HT-29 cells. CONCLUSION: One of the apoptotic mechanisms of paeonol is down-regulation of COX-2. p27 is upregulated simultaneously and plays an important part in controlling cell proliferation and is a crucial factor in the Fas/FasL apoptosis pathway. 展开更多
关键词 Peaonol HT-29 cell line CYCLOOXYGENASE-2 P27
下载PDF
Diagnosis of intestinal tuberculosis using a monoclonal antibody to Mycobacterium tuberculosis 被引量:12
17
作者 Yasushi Ihama Akira Hokama +9 位作者 Kenji Hibiya Kazuto Kishimoto Manabu Nakamoto Tetsuo Hirata Nagisa Kinjo Haley L Cash Futoshi Higa Masao Tateyama Fukunori Kinjo Jiro Fujita 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第47期6974-6980,共7页
AIM:To investigate the utility of immunohistochemical(IHC) staining with an antibody to Mycobacterium tuberculosis(M.tuberculosis) for the diagnosis of intestinal tuberculosis(TB).METHODS:We retrospectively identified... AIM:To investigate the utility of immunohistochemical(IHC) staining with an antibody to Mycobacterium tuberculosis(M.tuberculosis) for the diagnosis of intestinal tuberculosis(TB).METHODS:We retrospectively identified 10 patients(4 males and 6 females;mean age = 65.1 ± 13.6 years) with intestinal TB.Clinical characteristics,including age,gender,underlying disease,and symptoms were obtained.Chest radiograph and laboratory tests,including sputum Ziehl-Neelsen(ZN) staining,M.tuberculosis culture,and sputum polymerase chain reaction(PCR) for tubercle bacilli DNA,as well as Tuberculin skin test(TST) and QuantiFERON-TB gold test(QFT),were examined.Colonoscopic records recorded on the basis of Sato's classification were also reviewed,in addition to data from intestinal biopsies examined for histopathological findings,including hematoxylin and eosin staining,and ZN staining,as well as M.tuberculosis culture,and PCR for tubercle bacilli DNA.For the present study,archived formalin-fixed paraffin-embedded(FFPE) intestinal tissue samples were immunohistochemically stained using a commercially available species-specific monoclonal antibody to the 38-kDa antigen of the M.tuberculosis complex.These sections were also stained with the pan-macrophage marker CD68 antibody.RESULTS:From the clinical data,we found that no patients were immunocompromised,and that the main symptoms were diarrhea and weight loss.Three patients displayed active pulmonary TB,six patients(60%) had a positive TST,and 4 patients(40%) had a positive QFT.Colonoscopic findings revealed that all patients had type 1 findings(linear ulcers in a circumferential arrangement or linear ulcers arranged circumferentially with mucosa showing multiple nodules),all of which were located in the right hemicolon and/or terminal ileum.Seven patients(70%) had concomitant healed lesions in the ileocecal area.No acid-fast bacilli were detected with ZN staining of the intestinal tissue samples,and both M.tuberculosis culture and PCR for tubercle bacilli DNA were negative in all samples.The histopathological data revealed that tuberculous granulomas were present in 4 cases(40%).IHC staining in archived FFPE samples with anti-M.tuberculosis monoclonal antibody revealed positive findings in 4 patients(40%);the same patients in which granulomas were detected by hematoxylin and eosin staining.M.tuberculosis antigens were found to be mostly intracellular,granular in pattern,and primarily located in the CD68 + macrophages of the granulomas.CONCLUSION:IHC staining with a monoclonal antibody to M.tuberculosis may be an efficient and simple diagnostic tool in addition to classic examination methods for the diagnosis of intestinal TB. 展开更多
关键词 COLONOSCOPY Intestinal tuberculosis IMMUNOHISTOCHEMISTRY Monoclonal antibody Mycobacterium tuberculosis
下载PDF
Human epidermal growth factor receptor-2 gene amplification in gastric cancer using tissue microarray technology 被引量:9
18
作者 Dimitrios Tsapralis Ioannis Panayiotides +2 位作者 George Peros Theodore Liakakos Eva Karamitopoulou 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第2期150-155,共6页
AIM:To assess human epidermal growth factor receptor-2 (HER2)-status in gastric cancer and matched lymph node metastases by immunohistochemistry (IHC) and chromogenic in situ hybridization (CISH).METHODS:120 cases of ... AIM:To assess human epidermal growth factor receptor-2 (HER2)-status in gastric cancer and matched lymph node metastases by immunohistochemistry (IHC) and chromogenic in situ hybridization (CISH).METHODS:120 cases of primary gastric carcinomas and 45 matched lymph node metastases from patients with full clinicopathological features were mounted onto multiple-punch and single-punch tissue microarrays,respectively,and examined for HER2 overexpression and gene amplification by IHC and CISH.RESULTS:Twenty-four tumors (20%) expressed HER2 immunohistochemically.An IHC score of ≥ 2+ was observed in 20 tumors (16.6%).HER2 amplification was detected by CISH in 19 tumors (15.8%) and in their matched lymph node metastases.A high concordancerate was found between HER2 positivity (as detected by IHC) and HER2 gene amplification (as detected by CISH),since 19 of the 20 IHC positive cases were amplified (95%).All amplified cases had 2+ or 3+ IHC results.Amplification was associated with intestinal phenotype (P < 0.05).No association with grading,staging or survival was found.CONCLUSION:In gastric cancer,HER2 amplification is the main mechanism for HER2 protein overexpression and is preserved in lymph node metastases. 展开更多
关键词 Human epidermal growth factor receptor-2 IMMUNOHISTOCHEMISTRY Chromogenic in situ hybridiza-tion Gastric cancer
下载PDF
Preparation and Characterization of Monoclonal Antibodies against VP1 Protein of Foot-and-mouth Disease Virus O/China99
19
作者 Shuai SONG Tong LIN +4 位作者 Jun-jun SHAO Shan-dian GAO Guo-zheng CONG Jun-zheng DU Hui-yun CHANG 《Virologica Sinica》 SCIE CAS CSCD 2009年第6期566-572,共7页
Monoclonal antibodies (McAbs) 1A9 and 9F12 against Foot-and-mouth disease virus (FMDV) serotype O were produced by fusing SP2/0 myeloma cells with splenocyte from the mouse immunized with O/China99. Both McAbs reacted... Monoclonal antibodies (McAbs) 1A9 and 9F12 against Foot-and-mouth disease virus (FMDV) serotype O were produced by fusing SP2/0 myeloma cells with splenocyte from the mouse immunized with O/China99. Both McAbs reacted with O/China99 but not with Asia 1, as determined by immunohistochemistry assay. The microneutralization titer of the McAbs 1A9 and 9F12 were 640 and 1 280, respectively. Both McAbs contain kappa light chains, but the McAbs 1A9 and 9F12 were IgG1 and IgM, respectively. In order to define the McAbs binding epitopes, the reactivity of these McAbs against VP1, P20 and P14 were examined using indirect ELISA, the result showed that both McAbs reacted with VP1 and P20. McAbs may be used for further studies of vaccine, diagnostic methods, prophylaxis, etiological and immunological researches on FMDV. 展开更多
关键词 Foot-and-mouth disease virus (FMDV) Monoclonal antibody Neutralizing activity VP1 protein
下载PDF
颞下颌关节滑膜间充质干细胞的分离与培养 被引量:5
20
作者 李健 龙星 +2 位作者 柯金 孟庆功 房维 《中华口腔医学杂志》 CAS CSCD 北大核心 2005年第5期362-364,共3页
目的进行颞下颌关节滑膜间充质干细胞(SMSCs)的体外分离与培养。方法用有限稀释法筛选出SMSCs,并在25ml培养瓶中扩增培养。噻唑蓝法检测SMSCs的细胞生长周期,细胞免疫化学检测波形蛋白和角蛋白的表达,流式细胞技术对SMSCs进行CD8,CD34,C... 目的进行颞下颌关节滑膜间充质干细胞(SMSCs)的体外分离与培养。方法用有限稀释法筛选出SMSCs,并在25ml培养瓶中扩增培养。噻唑蓝法检测SMSCs的细胞生长周期,细胞免疫化学检测波形蛋白和角蛋白的表达,流式细胞技术对SMSCs进行CD8,CD34,CD44,血管细胞间黏附分子-1(VCAM-1)和细胞间黏附分子-1(ICAM-1)的检测。结果体外培养的SMSCs,细胞突起明显,细胞外形均匀一致,免疫染色显示波形蛋白阳性与角蛋白阴性。流式细胞仪检测发现其有CD44、VCAM-1和ICAM-1的表达。结论从成人的颞下颌关节滑膜中可以分离培养出SMSCs。 展开更多
关键词 颞下颌关节 滑膜 干细胞 间充质干细胞 关节滑膜 扩增培养 体外分离 颞下颌 细胞间黏附分子 免疫化学检测
原文传递
上一页 1 2 下一页 到第
使用帮助 返回顶部